GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Achillion Pharmaceuticals, Inc. (ACHN) [hlAlert]

Rating:
Outperform
ACHN
down 3.59 %

Achillion Pharmaceuticals, Inc. (ACHN) rated Outperform with price target $11 by Wedbush

Posted on: Tuesday,  Jul 26, 2011  9:25 AM ET by Wedbush

Wedbush rated Outperform Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) on 07/26/2011, when the stock price was $7.79. Since
then, Achillion Pharmaceuticals, Inc. has lost 3.59% as of 10/07/2015's recent price of $7.51.
If you would have followed this Wedbush 's recommendation on ACHN, you would have lost 3.59% of your investment in 1534 days.

Achillion Pharmaceuticals, Inc. (Achillion) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Within the anti-infective market, it focuses on the development of antivirals for the treatment of chronic hepatitis C and the development of antibacterials for the treatment of resistant bacterial infections. As of December 31, 2008, Achillion focused its efforts on advancing two late-stage preclinical candidates: ACH-1095, an NS4A antagonist for the treatment of chronic hepatitis C, being developed in collaboration with Gilead Sciences, Inc. (Gilead), and ACH-1625, a protease inhibitor also for the treatment of chronic hepatitis C. It has a pipeline of other product candidates, for which it is seeking appropriate collaborative partners. These product candidates include elvucitabine for the treatment of human immunodeficiency virus (HIV) infection and ACH-702 for the treatment of serious bacterial infections.

Wedbush is Headquartered in Los Angeles, California with over 90 offices and more than 125 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth. We deliver superior investment ideas and products through exceptional customer care, financial security, continuity and advanced technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/26/2011 9:25 AM Buy
None
7.79 11.00
as of 12/30/2011
1 Week down  -2.18 %
1 Month up  14.58 %
3 Months up  61.44 %
1 YTD down  -2.18 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy